Egypt’s SEDICO to complete EGP 300 mn pharmaceuticals factory by end-2019

SEDICO Pharmaceutical Company is planning to complete a EGP 300 mn antineoplastics factory by the end of 2019, Chairman Awad Gabr said. Antineoplastics are medicines used to prevent tumors. Gabr did not mention the location or capacity of the planned facility, but noted that production will begin in 2020.